T.N. Trofimtseva, S.K. Yarovoy, A.A. Gritskevich
Prevalence of chronic kidney disease among cancer patients
|
№11 / 2023
|
He Mingze, Zeng Zitong
Modern approaches to the treatment of muscle-invasive bladder cancer
|
№7 / 2022
|
I.V. Kosova (1, 2), O.B. Loran (1), L.A. Sinyakova (1), L.V. Gundorova (3), V.A. Kosov (4), I.E. Pogodina (5), D.N. Kolbasov (2)
PD-L1 EXPRESSION IN BLADDER CANCER AGAINST THE BACKGROUND OF CHRONIC HERPESVIRUS INFECTION: RESULTS OF A PILOT STUDY
|
№6 / 2018
|
A.D. Kaprin, A.A. Kostin, N.V. Vorobyev, S.V. Popov
MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF ACUTE PYELONEPHRITIS IN PATIENTS WITH BLADDER CANCER
|
№17 / 2017
|
O.B. Loran (1), L.A. Sinyakova (1), L.V. Gundorova (2), V.A. Kosov (3), I.V. Kosova (4), I.E. Pogodina (5), D.N. Kolbasov (4)
ONCOMODULATING EFFECT OF CYTOMEGALOVIRUS IN BLADDER CANCER: MYTH OR REALITY?
|
№3 / 2017
|
K.A. Vorontsova, L.G. Zhukova
MODERN POSSIBILITIES OF MEDICAL TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER
|
№8 / 2016
|
M.P. Golovaschenko, I.G. Rusakov
Risk-associated Therapy Of Muscular-noninvasive Bladder Cancer
|
№7 / 2011
|